Category: ENT

ENT, Gastroenterology

Use of #proton pump inhibitors to treat persistent #throat symptoms: multicentre, double blind, randomised, placebo controlled trial

To assess the use of proton pump inhibitors (PPIs) to treat persistent throat symptoms.. ..Random blinded allocation (1:1) to either 30 mg lansoprazole twice daily or matched placebo twice daily for 16 weeks. Main outcome measures Primary outcome was symptomatic response at 16 weeks measured using the total reflux symptom index (RSI) score. Secondary outcomes included symptom response at 12 months, quality of life, and … Continue reading Use of #proton pump inhibitors to treat persistent #throat symptoms: multicentre, double blind, randomised, placebo controlled trial

Rate This

aledopress
ENT, Environment, Infectivology

Lowering the transmission and spread of human coronavirus

The emergence of the severe acute respiratory syndrome coronavirus 2 pandemic has created an unprecedented healthcare, social, and economic disaster. Wearing of masks and social distancing can significantly decrease transmission and spread, however, due to circumstances such as medical or dental intervention and personal choice these practices have not been universally adopted. Additional strategies are required to lessen transmission. Nasal rinses and mouthwashes, which directly … Continue reading Lowering the transmission and spread of human coronavirus

Rate This

aledopress
Cardiology, ENT, Hypertension

Association of #Hypertension With the Risk and Severity of #Epistaxis

..Among the 35 749 patients in the hypertension cohort (20 579 men [57.6%]; median age, 52 years [interquartile range, 45-62 years]) the incidence rate (IR) of epistaxis was 32.97 per 10 000 persons (95% CI, 30.57-35.51 per 10 000 persons); among the 35 749 individuals in the comparison cohort (20 910 men [58.5%]; median age, 52 years [interquartile range, 45-62 years]), the IR of epistaxis was 22.76 per 10 000 persons (95% … Continue reading Association of #Hypertension With the Risk and Severity of #Epistaxis

Rate This

aledopress
ENT, Infectivology

AAO-HNS: #Anosmia, Hyposmia, and #Dysgeusia Symptoms of #Coronavirus Disease

Anecdotal evidence is rapidly accumulating from sites around the world that anosmia and dysgeusia are significant symptoms associated with the COVID-19 pandemic. Anosmia, in particular, has been seen in patients ultimately testing positive for the coronavirus with no other symptoms. We propose that these symptoms be added to the list of screening tools for possible COVID-19 infection. Anosmia, hyposmia, and dysgeusia in the absence of … Continue reading AAO-HNS: #Anosmia, Hyposmia, and #Dysgeusia Symptoms of #Coronavirus Disease

Rate This

aledopress